• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-200C 在功能缺失范可尼贫血通路肺癌中的表达。

MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers.

机构信息

Department of Human and Molecular Genetics, Herbert Wertheim College of Medicine, The Florida International University, Miami, FL, 33199, USA.

Biomolecular Sciences Institute, The Florida International University, Miami, FL, 33199, USA.

出版信息

Sci Rep. 2021 Feb 24;11(1):4420. doi: 10.1038/s41598-021-83884-9.

DOI:10.1038/s41598-021-83884-9
PMID:33627769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7904768/
Abstract

The Fanconi Anemia (FA) pathway is essential for human cells to maintain genomic integrity following DNA damage. This pathway is involved in repairing damaged DNA through homologous recombination. Cancers with a defective FA pathway are expected to be more sensitive to cross-link based therapy or PARP inhibitors. To evaluate downstream effectors of the FA pathway, we studied the expression of 734 different micro RNAs (miRNA) using NanoString nCounter miRNA array in two FA defective lung cancer cells and matched control cells, along with two lung tumors and matched non-tumor tissue samples that were deficient in the FA pathway. Selected miRNA expression was validated with real-time PCR analysis. Among 734 different miRNAs, a cluster of microRNAs were found to be up-regulated including an important cancer related micro RNA, miR-200C. MiRNA-200C has been reported as a negative regulator of epithelial-mesenchymal transition (EMT) and inhibits cell migration and invasion by promoting the upregulation of E-cadherin through targeting ZEB1 and ZEB2 transcription factors. miRNA-200C was increased in the FA defective lung cancers as compared to controls. AmpliSeq analysis showed significant reduction in ZEB1 and ZEB2 mRNA expression. Our findings indicate the miRNA-200C potentially play a very important role in FA pathway downstream regulation.

摘要

范可尼贫血(FA)途径对于人类细胞在 DNA 损伤后维持基因组完整性至关重要。该途径通过同源重组参与修复受损 DNA。FA 途径有缺陷的癌症预计对交联基治疗或 PARP 抑制剂更敏感。为了评估 FA 途径的下游效应物,我们使用 NanoString nCounter miRNA 阵列研究了两个 FA 缺陷肺癌细胞和匹配的对照细胞、两个肺癌肿瘤和匹配的非肿瘤组织样本中 734 种不同 microRNA(miRNA)的表达情况,这些样本在 FA 途径中存在缺陷。使用实时 PCR 分析验证了选定的 miRNA 表达。在 734 种不同的 miRNA 中,发现了一组 miRNA 上调,包括一种重要的癌症相关 miRNA,miR-200C。miR-200C 已被报道为上皮-间充质转化(EMT)的负调节剂,通过靶向 ZEB1 和 ZEB2 转录因子促进 E-钙粘蛋白的上调,从而抑制细胞迁移和侵袭。与对照相比,FA 缺陷型肺癌中 miR-200C 增加。AmpliSeq 分析显示 ZEB1 和 ZEB2 mRNA 表达显著降低。我们的研究结果表明,miR-200C 可能在 FA 途径的下游调控中发挥非常重要的作用。

相似文献

1
MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers.miRNA-200C 在功能缺失范可尼贫血通路肺癌中的表达。
Sci Rep. 2021 Feb 24;11(1):4420. doi: 10.1038/s41598-021-83884-9.
2
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.UBE2C 被 miR-548e-5p 直接靶向,增加了与非小细胞肺癌中 EMT 标志物蛋白锌指 E-box 结合同源框 1/2 相互作用的癌细胞的细胞生长和侵袭能力。
Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.
3
MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.微小RNA-200c通过靶向ZEB2(一种上皮-间质转化调节因子)抑制三阴性乳腺癌的转移。
Ann Clin Lab Sci. 2020 Jul;50(4):519-527.
4
Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.miR-200c/miR-141 在头颈部鳞状细胞癌上皮-间质转化和迁移中的调控作用。
Int J Mol Med. 2014 Apr;33(4):879-86. doi: 10.3892/ijmm.2014.1625. Epub 2014 Jan 14.
5
Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.厚朴酚通过在体外和体内调节ZEB1/E-钙黏蛋白轴来调控miR-200c-3p,从而抑制上皮-间质转化和视网膜母细胞瘤进展。
Phytomedicine. 2023 Feb;110:154597. doi: 10.1016/j.phymed.2022.154597. Epub 2022 Dec 12.
6
Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.下调的 microRNA-200a 通过靶向胃腺癌中的 E-钙黏蛋白抑制剂 ZEB1/ZEB2,通过 wnt/β-连环蛋白通路促进 EMT 和肿瘤生长。
Oncol Rep. 2013 Apr;29(4):1579-87. doi: 10.3892/or.2013.2267. Epub 2013 Jan 31.
7
Targets of miR-200c mediate suppression of cell motility and anoikis resistance.miR-200c 的靶标介导细胞迁移的抑制和抗失巢凋亡。
Breast Cancer Res. 2011 Apr 18;13(2):R45. doi: 10.1186/bcr2867.
8
Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.伊朗非小细胞肺癌中miR-9、miR-200c、ZEB1、ZEB2和E-钙黏蛋白的表达
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1633-1639. doi: 10.31557/APJCP.2019.20.6.1633.
9
miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.微小RNA-200c通过靶向锌指E盒结合同源框2(ZEB2)的表达来调节卵巢癌细胞的转移潜能。
Med Oncol. 2014 Aug;31(8):134. doi: 10.1007/s12032-014-0134-1. Epub 2014 Jul 23.
10
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.miR-448 通过直接靶向 E-钙黏蛋白抑制因子 ZEB1/2 抑制乳腺癌细胞的上皮-间充质转化。
Exp Biol Med (Maywood). 2018 Mar;243(5):473-480. doi: 10.1177/1535370218754848. Epub 2018 Jan 25.

引用本文的文献

1
Clinical implications of miRNAs in erythropoiesis, anemia, and other hematological disorders.miRNAs 在红细胞生成、贫血和其他血液系统疾病中的临床意义。
Mol Biol Rep. 2024 Oct 18;51(1):1064. doi: 10.1007/s11033-024-09981-w.
2
Identification of new RAD51D-regulating microRNAs that also emerge as potent inhibitors of the Fanconi anemia/homologous recombination pathways.鉴定新的 RAD51D 调节 microRNAs,它们也成为范可尼贫血/同源重组途径的有效抑制剂。
Hum Mol Genet. 2022 Dec 16;31(24):4241-4254. doi: 10.1093/hmg/ddac177.

本文引用的文献

1
Fanconi anemia pathway as a prospective target for cancer intervention.范可尼贫血通路作为癌症干预的潜在靶点。
Cell Biosci. 2020 Mar 16;10:39. doi: 10.1186/s13578-020-00401-7. eCollection 2020.
2
Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.伊朗非小细胞肺癌中miR-9、miR-200c、ZEB1、ZEB2和E-钙黏蛋白的表达
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1633-1639. doi: 10.31557/APJCP.2019.20.6.1633.
3
The Fanconi Anemia Pathway in Cancer.癌症中的范可尼贫血通路。
Annu Rev Cancer Biol. 2019 Mar;3:457-478. doi: 10.1146/annurev-cancerbio-030617-050422. Epub 2018 Dec 3.
4
Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.microRNA-200c 的表达水平与体外细胞形态和组织学分化有关,通过调节胃癌中的 ZEB1/2 和 E-钙黏蛋白。
Oncol Rep. 2018 Jan;39(1):91-100. doi: 10.3892/or.2017.6093. Epub 2017 Nov 10.
5
MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.微小RNA-200c增强具有激活的表皮生长因子受体相关信号传导的人类癌细胞的放射敏感性。
Oncotarget. 2017 Jul 3;8(39):65457-65468. doi: 10.18632/oncotarget.18924. eCollection 2017 Sep 12.
6
microRNAs Make the Call in Cancer Personalized Medicine.微小RNA在癌症个性化医疗中发挥关键作用。
Front Cell Dev Biol. 2017 Sep 22;5:86. doi: 10.3389/fcell.2017.00086. eCollection 2017.
7
DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.通过范可尼贫血 DNA 修复途径观察 DNA 损伤反应和癌症治疗。
Cell Commun Signal. 2017 Oct 10;15(1):41. doi: 10.1186/s12964-017-0195-9.
8
MicroRNAs and Cancer: A Long Story for Short RNAs.微小 RNA 与癌症:短 RNA 的长篇故事。
Adv Cancer Res. 2017;135:1-24. doi: 10.1016/bs.acr.2017.06.005. Epub 2017 Aug 12.
9
MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.微小RNA-200c通过靶向高迁移率族蛋白B1抑制肺癌的上皮-间质转化、侵袭和迁移。
PLoS One. 2017 Jul 20;12(7):e0180844. doi: 10.1371/journal.pone.0180844. eCollection 2017.
10
Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.泛素连接酶RFWD3的双等位基因突变会导致范可尼贫血。
J Clin Invest. 2017 Aug 1;127(8):3013-3027. doi: 10.1172/JCI92069. Epub 2017 Jul 10.